Gilead Sciences to Acquire YM Biosciences
December 12, 2012
MEI Pharma Announces $27.5 Million Private Placement
November 5, 2012
Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing
October 24, 2012
Bard Acquires Neomend, Inc.
October 23, 2012
Pfizer To Acquire NextWave Pharmaceuticals, Inc.
October 22, 2012
Medtronic Signs Agreement to Acquire China Kanghui Holdings
September 27, 2012
SentreHEART Secures $26 Million in Series C Financing for Commercialization
Redwood City, CA – June 4, 2012
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Malvern, PA & Irvine, CA - July 19, 2011
Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering
Schaumburg, IL - April 20, 2011
AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
Aliso Viejo, CA - October 29, 2010
OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
Bothell, WA & Vancouver - October 18, 2010
Yaupon Announces Positive Results from Pivotal Study of its Proprietary Topical Mechlorethamine Gel; A Potential Treatment for Early-Stage Cutaneous T-Cell Lymphoma
Radnor, PA - August 10, 2010
China Kanghui Holdings Announces Pricing of Initial Public Offering
Changzhou, China - August 10, 2010
United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China
Silver Spring, MD - July 1, 2010
FDA Approves Sagent Pharmaceuticals, Inc.'s Heparin Sodium Injection, USP
Schaumburg, IL - July 1, 2010
Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
Malvern, PA - June 30, 2010
Lee's Pharm Accredited "Asia's Best Companies 2010 - (China) Best Small Cap" Ranked 2nd
Hong Kong - June 8, 2010
Dynavax Raises $44 Million Through Public Offering of Common Stock and Warrants
Berkeley, CA - April 13, 2010
Sagent Pharmaceuticals Raises $40 Million in Two Tranches of a Series B Financing
Schaumburg, IL - April 8, 2010
Merz to Acquire BioForm Medical
Frankfurt, Germany & San Mateo, CA - January 4, 2010
Lee's Pharmaceutical Signed a Subscription Agreement with Vivo Ventures Fund
Shatin, Hong Kong - August 12, 2009
AVANIR Announces Positive Phase III Study Results for Zenvia
Aliso Viejo, CA - August 11, 2009
Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
Palo Alto, CA - August 10, 2009
KangHui Medical Raises Series B-1 Extension Round
Palo Alto, CA - April 24, 2009
Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Palo Alto, CA - February 24, 2009
APT Pharmaceuticals Secures $32 Million in Series B Financing
Burlingame, CA - September 30, 2008
Sagent Completes $30 Million Series A Financing Extension
Schaumburg, IL - September 4, 2008
SpectraGenics Announces $30M in New Funding Changes Company Name to Tria Beauty
Pleasanton, CA - July 10, 2008
AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval
Palo Alto, CA - Nov 26, 2007
Carbylan Announces $20 Million Series B Financing
Aliso Viejo, CA - March 27, 2008
Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
Radnor, PA - Nov 26, 2007
BioForm Announces Pricing of Initial Public Offering
San Mateo, CA - Nov 07, 2007
APT Pharmaceuticals Closes New $22 Million Funding Round
Burlingame, CA - October 4, 2007
Sagent Pharmaceuticals Inc. Completes $53M Series A Financing
Schaumburg, IL - September 27, 2007
Acura Pharmaceuticals, Inc. secures financing to fund pivotal Phase III clinical trial for lead Aversion® technology product candidate
Palatine, IL - August 20, 2007
Capnia names chairman, CEO
Palo Alto, CA - August 6, 2007
Biodel Inc. Announces Completion of Public Offering
DANBURY, CT - May 17, 2007
